• Japanese
  • Korean
  • Chinese
Home > Publishers > GBI Research
Publisher
Filter

GBI Research Report List

GBI Research publishes in-depth strategic intelligence reports in a broad range of professional industries, including, pharmaceuticals, medical devices, alternative energy, power, clean technology, oil and gas and chemicals. Their reports draw on in-depth primary and secondary research, proprietary databases and high quality analysis from their in house and external expert teams. Insights and analysis at the company, country and industry level includes competitor and market data, valuations, clinical & market trends, product pipelines and forecasts.

Filter
Title Search
1 - 25 of 541 Products Sort by Display
Type 2 Diabetes Mellitus Therapeutics in Asia-Pacific Markets to 2021 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth
Published by
GBI Research
Published
January 1, 2016
Content info
166 Pages
Price
USD 4995
Sample available
Frontier Pharma: Parkinson's Disease - Identifying and Commercializing First-in-Class Innovation
Published by
GBI Research
Published
January 1, 2016
Content info
95 Pages
Price
USD 6995
Sample available
Frontier Pharma: Chronic Obstructive Pulmonary Disease (COPD) - Identifying and Commercializing First-in-Class Innovation
Published by
GBI Research
Published
December 16, 2015
Content info
53 Pages
Price
USD 6995
Sample available
Breast Cancer Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rapid Uptake of Premium Priced Biologics and Rising Incidence
Published by
GBI Research
Published
December 15, 2015
Content info
170 Pages
Price
USD 4995
Sample available
Global Immunology Market to 2022 - Large pipeline and competitive market to drive long-term market growth
Published by
GBI Research
Published
December 1, 2015
Content info
133 Pages
Price
USD 4995
Sample available
Pancreatic Cancer Therapeutics in Major Developed Markets to 2021 - Strong Late Stage Pipeline Holds Promise for Increasingly Diverse Market Landscape
Published by
GBI Research
Published
December 1, 2015
Content info
138 Pages
Price
USD 4995
Sample available
Frontier Pharma: Ovarian Cancer - Identifying and Commercializing First-in-Class Innovation
Published by
GBI Research
Published
December 1, 2015
Content info
65 Pages
Price
USD 6995
Sample available
COPD Therapeutics in Major Developed Markets to 2021 - Emergence of Addition-in-Class and First-in-Class Products Offsets Sales Erosion of Leading Brands
Published by
GBI Research
Published
November 13, 2015
Content info
122 Pages
Price
USD 4995
Sample available
Prostate Cancer Market to 2021 - Increasing Disease Prevalence to be a Key Driver of Market Growth
Published by
GBI Research
Published
November 1, 2015
Content info
164 Pages
Price
USD 4995
Sample available
Type 1 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 - Innovative and Diversified Pipeline to Drive Market Growth Despite Patent Expirations
Published by
GBI Research
Published
November 1, 2015
Content info
159 Pages
Price
USD 4995
Sample available
Frontier Pharma: Obesity - Identifying and Commercializing First-in-Class Innovation
Published by
GBI Research
Published
October 1, 2015
Content info
87 Pages
Price
USD 6995
Sample available
Multiple Myeloma Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Rising Prevalence, Continued Success of Velcade, Revlimid and Emerging Supplementary Treatments
Published by
GBI Research
Published
October 1, 2015
Content info
117 Pages
Price
USD 4995
Sample available
Pharmaceutical Deal Trends (2010-2015) and In-Depth Analysis of Recent Deal Activity
Published by
GBI Research
Published
October 1, 2015
Content info
77 Pages
Price
USD 2995
Sample available
Non-Small Cell Lung Cancer Therapeutics in Major Developed Markets to 2021 - Emergence of Immunotherapies Drives Market Growth and Creates A Competitive Second-Line
Published by
GBI Research
Published
September 1, 2015
Content info
113 Pages
Price
USD 4995
Sample available
Hepatitis B Therapeutics in Major Developed Markets to 2021 - Increasing Number of Migrants from High-Prevalence Regions to Drive Market Growth
Published by
GBI Research
Published
September 1, 2015
Content info
78 Pages
Price
USD 4995
Sample available
Frontier Pharma: Innovative Licensing Opportunities in Non-Hodgkin Lymphoma
Published by
GBI Research
Published
August 6, 2015
Content info
115 Pages
Price
USD 6995
Sample available
Type 2 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 - Strong Pipeline and Expanding Treatment Population to Encourage Robust Growth
Published by
GBI Research
Published
July 3, 2015
Content info
179 Pages
Price
USD 4995
Sample available
Multiple Myeloma Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rising Prevalence, Continued Success of Revlimid and Emerging Supplementary Treatments
Published by
GBI Research
Published
July 1, 2015
Content info
119 Pages
Price
USD 4995
Sample available
Frontier Pharma: Versatile Innovation in Oncology - Identifying and Commercializing Versatile First-in-Class Innovation
Published by
GBI Research
Published
July 1, 2015
Content info
108 Pages
Price
USD 6995
Sample available
Anti-hypertensive Therapeutics in Asia-Pacific Markets to 2021 - Increasing Prevalence of Hypertension Drives Market Growth despite Weak Pipeline
Published by
GBI Research
Published
July 1, 2015
Content info
82 Pages
Price
USD 4995
Sample available
Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation
Published by
GBI Research
Published
June 1, 2015
Content info
88 Pages
Price
USD 6995
Sample available
Frontier Pharma: Duchenne Muscular Dystrophy and Becker Muscular Dystrophy - Identifying and Commercializing First-in-Class Innovation
Published by
GBI Research
Published
May 1, 2015
Content info
77 Pages
Price
USD 6995
Sample available
Systemic Psoriasis Therapeutics in Asia-Pacific Markets to 2021 - Advent of Novel Biologics and Expanding Treatment Pool to Drive Growth
Published by
GBI Research
Published
May 1, 2015
Content info
94 Pages
Price
USD 4995
Sample available
Frontier Pharma: Asthma - Identifying and Commercializing First-in-Class Innovation
Published by
GBI Research
Published
May 1, 2015
Content info
67 Pages
Price
USD 6995
Sample available
Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2021 - Novel IL-6 and JAK Inhibitors to Stimulate Moderate Growth Despite Brand Erosion of Blockbuster Anti-TNFs
Published by
GBI Research
Published
May 1, 2015
Content info
126 Pages
Price
USD 4995
Sample available